- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tandem Diabetes Care Inc (TNDM)
Tandem Diabetes Care Inc stock price live, this page displays NASDAQ TNDM stock exchange data. View the TNDM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tandem Diabetes Care Inc real time stock price chart below.
What Is the Tandem Diabetes Care Inc Stock Price Today?
The Tandem Diabetes Care Inc stock price today is 16.35.
What Is the Stock Symbol for Tandem Diabetes Care Inc?
The stock symbol for Tandem Diabetes Care Inc is ""TNDM.""
What Stock Exchange Does Tandem Diabetes Care Inc Trade On?
Tandem Diabetes Care Inc is listed and trades on the NASDAQ stock exchange.
Is Tandem Diabetes Care Inc a Good Stock to Buy?
Determining whether Tandem Diabetes Care Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TNDM quote. (ISIN: US8753722037)
What Is the Tandem Diabetes Care Inc Stock Price Today?
The Tandem Diabetes Care Inc stock price today is 16.35.
What Is the Stock Symbol for Tandem Diabetes Care Inc?
The stock symbol for Tandem Diabetes Care Inc is ""TNDM.""
What Stock Exchange Does Tandem Diabetes Care Inc Trade On?
Tandem Diabetes Care Inc is listed and trades on the NASDAQ stock exchange.
Is Tandem Diabetes Care Inc a Good Stock to Buy?
Determining whether Tandem Diabetes Care Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TNDM quote. (ISIN: US8753722037)
Currency in USD
16.35
-0.49(-2.91%)
Real-time Data·
Fair Value
An estimate of a Tandem Diabetes Care's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.34
17.19
52 wk Range
14.31
47.60
TNDM Scorecard
Full Analysis
Significant return over the last week
Earnings results expected in 8 days
More Info
Fair Value
An estimate of a Tandem Diabetes Care's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.3417.19
52 wk Range
14.3147.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TNDM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Tandem Diabetes Care's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
31.10
Upside
+90.21%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Tandem Dtes Care receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Tandem Dtes Care receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Tandem Dtes Care receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Tandem Diabetes Care Inc Company Profile
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company’s flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Tandem Diabetes Care Inc SWOT Analysis
Market Dynamics | Explore Tandem's position in the durable insulin pump market, facing growth challenges amid intensifying competition and market share fluctuations |
Financial Outlook | Delve into Tandem's financial performance, with strong sales growth contrasting negative EPS forecasts and conservative guidance for future periods |
Innovation Pipeline | Uncover how Tandem's upcoming product launches could reinvigorate its market position, potentially accelerating growth beyond current mid-single-digit projections |
Analyst Perspectives | Discover varied analyst views on Tandem's potential, with price targets ranging from $22 to $53, reflecting the complex landscape of challenges and opportunities |
Tandem Diabetes Care Inc Earnings Call Summary for Q1/2025
- Q1 2025 EPS of -1.97 missed forecast, but revenue reached $234M, up 22% YoY; stock rose 5.52% in aftermarket trading
- U.S. sales up 15%, international sales surged 35%; company targets gross margin of 54% in 2025, potential 60% by 2026
- 2025 worldwide sales projected between $997M-$1B; U.S. sales $725M-$730M, international $272M-$277M
- CEO confident in strategic direction; CFO notes stable contract structures supporting revenue growth
- Challenges include EPS miss, cost management, competitive landscape, and potential global economic impacts
Last Updated: 30/04/2025, 22:36
Read Full TranscriptCompare TNDM to Peers and Sector
Metrics to compare | TNDM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTNDMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.1x | −4.4x | −0.5x | |
PEG Ratio | 0.21 | −0.28 | 0.00 | |
Price/Book | 7.2x | 2.9x | 2.6x | |
Price / LTM Sales | 1.1x | 3.4x | 3.2x | |
Upside (Analyst Target) | 57.8% | 37.7% | 41.2% | |
Fair Value Upside | Unlock | 7.4% | 6.2% | Unlock |
Analyst Ratings
10 Buy
10 Hold
2 Sell
Ratings:
22 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 31.10
(+90.21% Upside)
Earnings
Latest Release
Apr 30, 2025
EPS / Forecast
-1.97 / -0.60
Revenue / Forecast
234.40M / 220.30M
People Also Watch
FAQ
What Stock Exchange Does Tandem Diabetes Care Trade On?
Tandem Diabetes Care is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Tandem Diabetes Care?
The stock symbol for Tandem Diabetes Care is "TNDM."
What Is the Tandem Diabetes Care Market Cap?
As of today, Tandem Diabetes Care market cap is 1.10B.
What Is Tandem Diabetes Care's Earnings Per Share (TTM)?
The Tandem Diabetes Care EPS (TTM) is -2.80.
When Is the Next Tandem Diabetes Care Earnings Date?
Tandem Diabetes Care will release its next earnings report on 05 Aug 2025.
From a Technical Analysis Perspective, Is TNDM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Tandem Diabetes Care Stock Split?
Tandem Diabetes Care has split 1 times.
How Many Employees Does Tandem Diabetes Care Have?
Tandem Diabetes Care has 2650 employees.
What is the current trading status of Tandem Diabetes Care (TNDM)?
As of 29 Jul 2025, Tandem Diabetes Care (TNDM) is trading at a price of 16.35, with a previous close of 16.84. The stock has fluctuated within a day range of 16.34 to 17.19, while its 52-week range spans from 14.31 to 47.60.
What Is Tandem Diabetes Care (TNDM) Price Target According to Analysts?
The average 12-month price target for Tandem Diabetes Care is USD31.1, with a high estimate of USD59 and a low estimate of USD14. 10 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Buy. The stock has an +90.21% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.